Polyanionic	B:C1610990
carbosilane	I:C1610990
dendrimers	O
prevent	O
hepatitis	O
C	I:C4288963
virus	I:C4288963
infection	I:C4288963
in	O
cell	O
culture	I:C0007585
.	O

Polyanionic	O
carbosilane	I:C1610990
dendrimers	B:C1563732
prevent	O
hepatitis	O
C	I:C4288963
virus	I:C4288963
infection	I:C4288963
in	O
cell	O
culture	I:C0007585
.	O

Polyanionic	O
carbosilane	I:C1610990
dendrimers	O
prevent	O
hepatitis	B:C4288963
C	I:C4288963
virus	I:C4288963
infection	I:C4288963
in	O
cell	O
culture	I:C0007585
.	O

Polyanionic	O
carbosilane	I:C1610990
dendrimers	O
prevent	O
hepatitis	O
C	I:C4288963
virus	I:C4288963
infection	I:C4288963
in	O
cell	B:C0007585
culture	I:C0007585
.	O

Hepatitis	B:C4288963
C	I:C4288963
virus	I:C4288963
(	I:C4288963
HCV	I:C4288963
)	I:C4288963
infection	I:C4288963
is	O
a	O
major	O
biomedical	O
problem	O
worldwide	O
.	O

Hepatitis	O
C	I:C4288963
virus	I:C4288963
(	I:C4288963
HCV	I:C4288963
)	I:C4288963
infection	I:C4288963
is	O
a	O
major	O
biomedical	B:C1879848
problem	O
worldwide	O
.	O

Hepatitis	O
C	I:C4288963
virus	I:C4288963
(	I:C4288963
HCV	I:C4288963
)	I:C4288963
infection	I:C4288963
is	O
a	O
major	O
biomedical	O
problem	B:C0033213
worldwide	O
.	O

Although	O
new	O
direct	O
antiviral	O
agents	O
(	O
DAAs	O
)	O
have	O
been	O
developed	O
for	O
the	O
treatment	B:C0087111
of	O
chronic	O
HCV	O
infection	I:C4288963
,	O
the	O
potential	O
emergence	O
of	O
resistant	O
virus	I:C1444092
variants	O
and	O
the	O
difficulties	O
to	O
implement	O
their	O
administration	O
worldwide	O
make	O
the	O
development	O
of	O
novel	O
antiviral	O
agents	I:C0003451
an	O
urgent	O
need	O
.	O

Although	O
new	O
direct	O
antiviral	O
agents	O
(	O
DAAs	O
)	O
have	O
been	O
developed	O
for	O
the	O
treatment	O
of	O
chronic	O
HCV	B:C4288963
infection	I:C4288963
,	O
the	O
potential	O
emergence	O
of	O
resistant	O
virus	I:C1444092
variants	O
and	O
the	O
difficulties	O
to	O
implement	O
their	O
administration	O
worldwide	O
make	O
the	O
development	O
of	O
novel	O
antiviral	O
agents	I:C0003451
an	O
urgent	O
need	O
.	O

Although	O
new	O
direct	O
antiviral	O
agents	O
(	O
DAAs	O
)	O
have	O
been	O
developed	O
for	O
the	O
treatment	O
of	O
chronic	O
HCV	O
infection	I:C4288963
,	O
the	O
potential	O
emergence	O
of	O
resistant	B:C1444092
virus	I:C1444092
variants	O
and	O
the	O
difficulties	O
to	O
implement	O
their	O
administration	O
worldwide	O
make	O
the	O
development	O
of	O
novel	O
antiviral	O
agents	I:C0003451
an	O
urgent	O
need	O
.	O

Although	O
new	O
direct	O
antiviral	O
agents	O
(	O
DAAs	O
)	O
have	O
been	O
developed	O
for	O
the	O
treatment	O
of	O
chronic	O
HCV	O
infection	I:C4288963
,	O
the	O
potential	O
emergence	O
of	O
resistant	O
virus	I:C1444092
variants	O
and	O
the	O
difficulties	O
to	O
implement	O
their	O
administration	O
worldwide	O
make	O
the	O
development	O
of	O
novel	O
antiviral	B:C0003451
agents	I:C0003451
an	O
urgent	O
need	O
.	O

Moreover	O
,	O
no	O
effective	O
vaccine	B:C0042210
is	O
available	O
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
transmission	O
of	O
the	O
virus	O
still	O
occurs	O
particularly	O
when	O
prophylactic	O
measures	I:C0481566
are	O
not	O
taken	O
.	O

Moreover	O
,	O
no	O
effective	O
vaccine	O
is	O
available	O
against	O
Hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
and	O
transmission	O
of	O
the	O
virus	O
still	O
occurs	O
particularly	O
when	O
prophylactic	O
measures	I:C0481566
are	O
not	O
taken	O
.	O

Moreover	O
,	O
no	O
effective	O
vaccine	O
is	O
available	O
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
transmission	B:C0242781
of	O
the	O
virus	O
still	O
occurs	O
particularly	O
when	O
prophylactic	O
measures	I:C0481566
are	O
not	O
taken	O
.	O

Moreover	O
,	O
no	O
effective	O
vaccine	O
is	O
available	O
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
transmission	O
of	O
the	O
virus	B:C0042776
still	O
occurs	O
particularly	O
when	O
prophylactic	O
measures	I:C0481566
are	O
not	O
taken	O
.	O

Moreover	O
,	O
no	O
effective	O
vaccine	O
is	O
available	O
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
transmission	O
of	O
the	O
virus	O
still	O
occurs	O
particularly	O
when	O
prophylactic	B:C0481566
measures	I:C0481566
are	O
not	O
taken	O
.	O

We	O
used	O
a	O
cell	O
-	O
based	O
system	O
to	O
screen	O
a	O
battery	O
of	O
polyanionic	B:C1610990
carbosilane	I:C1610990
dendrimers	O
(	O
polyanionic	O
carbosilane	I:C1563732
dendrimers	I:C1563732
)	O
to	O
identify	O
compounds	O
with	I:C0243095
antiviral	I:C0243095
activity	I:C0243095
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
show	O
that	O
they	O
inhibit	O
effective	O
virus	O
adsorption	I:C1721019
of	O
major	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
genotypes	O
.	O

We	O
used	O
a	O
cell	O
-	O
based	O
system	O
to	O
screen	O
a	O
battery	O
of	O
polyanionic	O
carbosilane	I:C1610990
dendrimers	B:C1563732
(	O
polyanionic	O
carbosilane	I:C1563732
dendrimers	I:C1563732
)	O
to	O
identify	O
compounds	O
with	I:C0243095
antiviral	I:C0243095
activity	I:C0243095
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
show	O
that	O
they	O
inhibit	O
effective	O
virus	O
adsorption	I:C1721019
of	O
major	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
genotypes	O
.	O

We	O
used	O
a	O
cell	O
-	O
based	O
system	O
to	O
screen	O
a	O
battery	O
of	O
polyanionic	O
carbosilane	I:C1610990
dendrimers	O
(	O
polyanionic	B:C1563732
carbosilane	I:C1563732
dendrimers	I:C1563732
)	O
to	O
identify	O
compounds	O
with	I:C0243095
antiviral	I:C0243095
activity	I:C0243095
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
show	O
that	O
they	O
inhibit	O
effective	O
virus	O
adsorption	I:C1721019
of	O
major	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
genotypes	O
.	O

We	O
used	O
a	O
cell	O
-	O
based	O
system	O
to	O
screen	O
a	O
battery	O
of	O
polyanionic	O
carbosilane	I:C1610990
dendrimers	O
(	O
polyanionic	O
carbosilane	I:C1563732
dendrimers	I:C1563732
)	O
to	O
identify	O
compounds	B:C0243095
with	I:C0243095
antiviral	I:C0243095
activity	I:C0243095
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
show	O
that	O
they	O
inhibit	O
effective	O
virus	O
adsorption	I:C1721019
of	O
major	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
genotypes	O
.	O

We	O
used	O
a	O
cell	O
-	O
based	O
system	O
to	O
screen	O
a	O
battery	O
of	O
polyanionic	O
carbosilane	I:C1610990
dendrimers	O
(	O
polyanionic	O
carbosilane	I:C1563732
dendrimers	I:C1563732
)	O
to	O
identify	O
compounds	O
with	I:C0243095
antiviral	I:C0243095
activity	I:C0243095
against	O
Hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
and	O
show	O
that	O
they	O
inhibit	O
effective	O
virus	O
adsorption	I:C1721019
of	O
major	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
genotypes	O
.	O

We	O
used	O
a	O
cell	O
-	O
based	O
system	O
to	O
screen	O
a	O
battery	O
of	O
polyanionic	O
carbosilane	I:C1610990
dendrimers	O
(	O
polyanionic	O
carbosilane	I:C1563732
dendrimers	I:C1563732
)	O
to	O
identify	O
compounds	O
with	I:C0243095
antiviral	I:C0243095
activity	I:C0243095
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
show	O
that	O
they	O
inhibit	O
effective	O
virus	B:C1721019
adsorption	I:C1721019
of	O
major	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
genotypes	O
.	O

We	O
used	O
a	O
cell	O
-	O
based	O
system	O
to	O
screen	O
a	O
battery	O
of	O
polyanionic	O
carbosilane	I:C1610990
dendrimers	O
(	O
polyanionic	O
carbosilane	I:C1563732
dendrimers	I:C1563732
)	O
to	O
identify	O
compounds	O
with	I:C0243095
antiviral	I:C0243095
activity	I:C0243095
against	O
Hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
show	O
that	O
they	O
inhibit	O
effective	O
virus	O
adsorption	I:C1721019
of	O
major	O
Hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
genotypes	O
.	O

Interestingly	O
,	O
one	O
of	O
the	O
polyanionic	B:C1563732
carbosilane	I:C1563732
dendrimers	I:C1563732
irreversibly	O
destabilized	O
infectious	O
virions	O
.	O

Interestingly	O
,	O
one	O
of	O
the	O
polyanionic	O
carbosilane	I:C1563732
dendrimers	I:C1563732
irreversibly	O
destabilized	O
infectious	O
virions	B:C0042760
.	O

This	O
compound	O
displays	O
additive	O
effect	O
in	O
combination	O
with	O
a	O
clinically	O
relevant	O
DAA	O
,	O
sofosbuvir	B:C2976303
.	O

Our	O
results	O
support	O
further	O
characterization	O
of	O
these	O
molecules	O
as	O
nanotools	O
for	O
the	O
control	O
of	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
spread	O
.	O

